A novel ligand-modified nanocomposite microparticles improved efficiency of quercetin and paclitaxel delivery in the non-small cell lung cancer

Abstract Chemotherapy is the first choice for the treatment of cancer but it is still limited by insufficient kill efficiency and drug resistance. These problems urgently need to be overcome in a way that minimizes damage to the body. In this study, we designed the nanocomposite microparticles (NMPs) modified by cetuximab (Cet) and loaded anti-tumor agents- quercetin (QUE) and paclitaxel (PTX)- for eliciting specific drugs homing and enhancing the killing efficiency of chemotherapy drugs (P/Q@CNMPs). Physicochemical characteristics results presented that P/Q@CNMPs have a suitable aerodynamic diameter and uniform morphology that could meet the requirements of particles deposition in the lung. And it also had the characteristics of sustained-release and pH-responsive which could release the agents in the right place and has a continuous effect. In vitro and in vivo analysis results presented that P/Q@CNMPs have the accuracy targeting ability and killing effect on non-small cell lung cancer (NSCLC) which express positive epidermal growth factor receptor (EGFR) on the membrane. Furthermore, this system also has low toxicity and good biocompatibility. These results demonstrated that P/Q@CNMPs could be a potential intelligent targeting strategy used for chemo-resistant NSCLC therapies.

[1]  Chenglei Li,et al.  Combined anti-hepatocellular carcinoma therapy inhibit drug-resistance and metastasis via targeting "substance P-hepatic stellate cells-hepatocellular carcinoma" axis. , 2021, Biomaterials.

[2]  S. Xie,et al.  Nanoplatform-based natural products co-delivery system to surmount cancer multidrug-resistant. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Wentong Li,et al.  Targeted delivery of quercetin by nanoparticles based on chitosan sensitizing paclitaxel-resistant lung cancer cells to paclitaxel. , 2021, Materials science & engineering. C, Materials for biological applications.

[4]  Yukun Zhang,et al.  Traditional Chinese medicine combined with pulmonary drug delivery system and idiopathic pulmonary fibrosis: Rationale and therapeutic potential , 2020, Biomedicine & Pharmacotherapy.

[5]  S. M. Taghdisi,et al.  Self-assembled polymeric vesicles: Focus on polymersomes in cancer treatment. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[6]  L. Ouyang,et al.  Folate-mediated one-carbon metabolism: a targeting strategy in cancer therapy. , 2020, Drug discovery today.

[7]  A. Cruz,et al.  Pulmonary surfactant and drug delivery: Vehiculization, release and targeting of surfactant/tacrolimus formulations. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[8]  Huile Gao,et al.  The progress and perspective of strategies to improve tumor penetration of nanomedicines , 2020 .

[9]  Jing‐Yan Han,et al.  Combination of tumour-infarction therapy and chemotherapy via the co-delivery of doxorubicin and thrombin encapsulated in tumour-targeted nanoparticles , 2020, Nature Biomedical Engineering.

[10]  Dong-Hua Yang,et al.  Quercetin overcomes colon cancer cells resistance to chemotherapy by inhibiting solute carrier family 1, member 5 transporter. , 2020, European journal of pharmacology.

[11]  Zhiyuan Zhong,et al.  Dually Active Targeting Nanomedicines Based on a Direct Conjugate of Two Purely Natural Ligands for Potent Chemotherapy of Ovarian Tumor. , 2019, ACS applied materials & interfaces.

[12]  Samantha A. Meenach,et al.  Development and Evaluation of Paclitaxel-Loaded Aerosol Nanocomposite Microparticles and Their Efficacy Against Air-Grown Lung Cancer Tumor Spheroids. , 2019, ACS biomaterials science & engineering.

[13]  Jun Liang,et al.  The size-controllable preparation of chitosan/silver nanoparticle composite microsphere and its antimicrobial performance. , 2019, Carbohydrate polymers.

[14]  Mingwei Chen,et al.  Cetuximab and Doxorubicin loaded dextran-coated Fe3O4 magnetic nanoparticles as novel targeted nanocarriers for non-small cell lung cancer , 2019, Journal of Magnetism and Magnetic Materials.

[15]  M. Sakuragi,et al.  Preparation, Characterization, and in Vitro/in Vivo Evaluation of Paclitaxel-Bound Albumin-Encapsulated Liposomes for the Treatment of Pancreatic Cancer , 2019, ACS omega.

[16]  Heebeom Koo,et al.  Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems , 2019, Cancers.

[17]  Jiaqi Yu,et al.  Codelivery of Adriamycin and P-gp Inhibitor Quercetin Using PEGylated Liposomes to Overcome Cancer Drug Resistance. , 2019, Journal of pharmaceutical sciences.

[18]  Christopher T. Johnson,et al.  Inhaled bacteriophage-loaded polymeric microparticles ameliorate acute lung infections , 2018, Nature Biomedical Engineering.

[19]  M. Keidar,et al.  Paclitaxel and quercetin nanoparticles co-loaded in microspheres to prolong retention time for pulmonary drug delivery , 2017, International journal of nanomedicine.

[20]  C. G. Mohan,et al.  In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts , 2017, International journal of nanomedicine.

[21]  R. Ambrus,et al.  Aerodynamic properties and in silico deposition of meloxicam potassium incorporated in a carrier-free DPI pulmonary system. , 2017, International journal of pharmaceutics.

[22]  Samantha A. Meenach,et al.  Nanocomposite microparticles (nCmP) for the delivery of tacrolimus in the treatment of pulmonary arterial hypertension. , 2016, International journal of pharmaceutics.

[23]  Shyh-Dar Li,et al.  Modifying the tumor microenvironment using nanoparticle therapeutics. , 2016, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[24]  Qing Jiang,et al.  Dual-Ligand Modified Polymer-Lipid Hybrid Nanoparticles for Docetaxel Targeting Delivery to Her2/neu Overexpressed Human Breast Cancer Cells. , 2015, Journal of biomedical nanotechnology.

[25]  P. Majumder,et al.  Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition , 2015, Nature Communications.

[26]  Jing Du,et al.  Prostate stem cell antigen antibody-conjugated multiwalled carbon nanotubes for targeted ultrasound imaging and drug delivery. , 2014, Biomaterials.

[27]  H. Chan,et al.  Pulmonary drug delivery. , 2013, Therapeutic delivery.

[28]  N. Kneteman,et al.  Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity. , 2013, Biomaterials.

[29]  S. Nair,et al.  Cetuximab conjugated O-carboxymethyl chitosan nanoparticles for targeting EGFR overexpressing cancer cells. , 2013, Carbohydrate polymers.

[30]  Xin Wang,et al.  Cellular uptake, antitumor response and tumor penetration of cisplatin-loaded milk protein nanoparticles. , 2013, Biomaterials.

[31]  Sang‐wook Lee,et al.  Intracytoplasmic epidermal growth factor receptor shows poor response to the cetuximab antitumor effect in irradiated non-small cell lung cancer cell lines. , 2012, Lung cancer.

[32]  J. Dufour,et al.  Cell lines , 2012, Spermatogenesis.

[33]  Dean Ho,et al.  Multimodal Nanodiamond Drug Delivery Carriers for Selective Targeting, Imaging, and Enhanced Chemotherapeutic Efficacy , 2011, Advanced materials.

[34]  C. Bokemeyer,et al.  Platinum-based chemotherapy plus cetuximab in head and neck cancer. , 2008, The New England journal of medicine.

[35]  N. K. Jain,et al.  Surface-engineered dendrimers for dual drug delivery: A receptor up-regulation and enhanced cancer targeting strategy , 2008, Journal of drug targeting.

[36]  N. Ktistakis,et al.  Phosphatidic acid- and phosphatidylserine-binding proteins. , 2006, Biochimica et biophysica acta.